Oscar Health Inc vs Americas Gold and Silver Corporation Common Shares no par value — how do they compare? Oscar Health Inc trades at $34 (market cap $10.59B), while Americas Gold and Silver Corporation Common Shares no par value trades at $3.78 (market cap $1.26B). The key difference: Oscar Health Inc is far larger — about 8.4× Americas Gold and Silver Corporation Common Shares no par value's market cap, and Oscar Health Inc is trading nearer its 52-week high, Americas Gold and Silver Corporation Common Shares no par value nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Americas Gold and Silver Corporation Common Shares no par value for 0 Days on average.
| OSCR | USAS | |
|---|---|---|
Market Cap | $10.59B | $1.26B |
Volume | 5,280,571 | 3,948,671 |
Sector | Health | Basic Materials |
52-Week High | $34.32 | $10.03 |
52-Week Low | $10.85 | $3.59 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | $6.95B | $1.19B |
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $33.79, down 0.65% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B projected for 2026, with profitability turning positive from a $443M loss to $551M net income. Recent earnings beats in Q1 and Q2 2026 exceeded expectations by significant margins, while analyst sentiment remains mixed with a $34.75 consensus target slightly above current levels.
OSCR presents a growth story with expanding market share in ACA plans and improved medical loss ratios, though profitability remains sensitive to medical cost trends. The stock faces near-term resistance at $35 with RSI suggesting potential overbought conditions. Key risks include execution on growth targets and healthcare cost pressures, while institutional interest remains strong with recent price target upgrades following positive guidance.
USAS trades at $4.02, down 4.29% on the day, reflecting ongoing volatility amid mixed operational performance. The company reported a net loss of $87.45M in 2025, though revenue is projected to grow to $182M in 2026 with a narrowing loss. Recent news highlights progress at its Galena and Cosalá mines, including high-grade silver discoveries and sustainability initiatives, signaling potential for future production growth.
The outlook is speculative, with high-risk turnaround potential driven by operational improvements and exposure to silver and critical minerals. Key risks include persistent negative profitability, high valuation multiples like EV/EBITDA of 455.68, and reliance on successful mine development. Analyst consensus is unanimously bullish, but investors must weigh execution risks against long-term growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →Americas Gold and Silver Corporation is a Canada-based mining company that explores for and produces silver, along with by-product gold, copper, lead, and zinc. Its operating assets include the Galena Complex in Idaho and the Cosalá Operations in Sinaloa, Mexico.
Read more on USAS →